FDA halts emergency approval of COVID-19 blood plasma treatment

The Food and Drug Administration's emergency authorization for blood plasma as a treatment for the coronavirus has been put on hold to allow for more data to be reviewed, according to a report. An emergency approval could still be issued by the FDA in the near future, H. Clifford Lane, clinical director at the National...